GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 793 filers reported holding GLAXOSMITHKLINE PLC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,972,000 | +9.3% | 169,621 | -0.8% | 0.06% | +1.9% |
| Q3 2019 | $7,297,000 | +4.4% | 170,941 | -2.1% | 0.05% | 0.0% |
| Q2 2019 | $6,990,000 | -1.1% | 174,625 | +3.2% | 0.05% | -6.9% |
| Q1 2019 | $7,071,000 | +21.6% | 169,185 | +11.2% | 0.06% | +1.8% |
| Q4 2018 | $5,817,000 | +5.0% | 152,198 | +10.4% | 0.06% | +1.8% |
| Q3 2018 | $5,541,000 | +17.4% | 137,904 | +17.8% | 0.06% | -13.8% |
| Q2 2018 | $4,718,000 | +1.2% | 117,051 | -1.9% | 0.06% | +1.6% |
| Q1 2018 | $4,663,000 | +9.0% | 119,295 | -1.1% | 0.06% | +12.3% |
| Q4 2017 | $4,277,000 | +4.1% | 120,590 | +19.2% | 0.06% | -12.3% |
| Q3 2017 | $4,109,000 | +9.3% | 101,199 | +16.1% | 0.06% | -1.5% |
| Q2 2017 | $3,759,000 | +16.5% | 87,194 | +14.0% | 0.07% | +1.5% |
| Q1 2017 | $3,226,000 | +18.7% | 76,503 | +8.4% | 0.06% | +6.6% |
| Q4 2016 | $2,718,000 | -9.1% | 70,556 | +1.8% | 0.06% | -15.3% |
| Q3 2016 | $2,991,000 | +4.5% | 69,331 | +4.8% | 0.07% | -4.0% |
| Q2 2016 | $2,863,000 | – | 66,125 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |